Status:
COMPLETED
Short Term Efficacy of a Starting Dose of 12.5 mg of Prednisone in Polymyalgia Rheumatica Patients
Lead Sponsor:
University of Genova
Conditions:
Polymyalgia Rheumatica
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR-BHPR gui...
Eligibility Criteria
Inclusion
- patients with PMR, diagnosed according to the criteria of Bird et al
Exclusion
- patients with arthritis
- patients with giant cell arteritis
- patients with Parkinson's disease
- patients with hypothyroidism
- patients with scapulohumeral periarthritis
- patients with fibromyalgia
- patients unable to cooperate
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01169597
Start Date
January 1 2009
End Date
May 1 2010
Last Update
July 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica Reumatologica, Dipartimento di medicina Interna, Università di Genova
Genova, Italy, 16132